Lung Cancer
A Phase III, Randomised, Open-Label, Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung17, D763QC00001)
- Details
ClinicalTrials.gov ID:
NCT07291037
Diagnosis Type:
NA
USOR Number:
- Address
,
P: